Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Neurology(R) Neuroimmunology & Neuroinflammation|October 26, 2021
CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune EncephalitisMarc Dürr, Gunnar Nissen, Kurt-Wolfram Sühs, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.Journal of the Neurological Sciences|January 7, 2023
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy responseMarie Madlener, Christine Strippel, Franziska S Thaler, et al.Neurology|January 27, 2022
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCENMO StudyMartin W Hümmert, Louisa M Schöppe, Judith Bellmann-Strobl, et al.Journal of Neuroinflammation|January 21, 2022
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patientsSven Jarius, Florence Pache, Peter Körtvelyessy, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.Neurological Research and Practice|March 6, 2024
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS studyAntonios Bayas, Ulrich Mansmann, Begum Irmak Ön, et al.Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.Pageof 7